The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), Corcept Therapeutics's share price is $22.28. Corcept Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was $4.90. Hence, Corcept Therapeutics's PB Ratio of today is 4.55.
Good Sign:
Corcept Therapeutics Inc stock PB Ratio (=4.59) is close to 1-year low of 4.4
The historical rank and industry rank for Corcept Therapeutics's PB Ratio or its related term are showing as below:
CORT'
s PB Ratio Range Over the Past 10 Years
Min: 3.17 Med: 6.16 Max: 86.18
Current: 4.55
During the past 13 years, Corcept Therapeutics's highest PB Ratio was 86.18. The lowest was 3.17. And the median was 6.16.
CORT's PB Ratio is ranked worse than 74.37% of 1311
companies
in the Biotechnology industry
Industry Median: 2.37
vs CORT: 4.55
During the past 12 months, Corcept Therapeutics's average Book Value Per Share Growth Rate was 5.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 13.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Corcept Therapeutics was 142.10% per year. The lowest was -43.10% per year. And the median was 12.70% per year.
Back to Basics: PB Ratio
Corcept Therapeutics PB Ratio Historical Data
The historical data trend for Corcept Therapeutics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Corcept Therapeutics's PB Ratio
For the Biotechnology subindustry, Corcept Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corcept Therapeutics's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Corcept Therapeutics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Corcept Therapeutics's PB Ratio falls into.
Corcept Therapeutics PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Corcept Therapeutics's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Corcept Therapeutics (NAS:CORT) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Corcept Therapeutics PB Ratio Related Terms
Thank you for viewing the detailed overview of Corcept Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Corcept Therapeutics (Corcept Therapeutics) Business Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CORT has been successfully added to your 